Browse articles from EyeWorld.org related to keratoconus. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

Cataract surgery in patients with keratoconus

When performing cataract surgery in patients with keratoconus, there are considerations for surgical planning, lenses, and techniques that surgeons need to account for to ensure success. Two ophthalmologists discussed how they handle these patients, including testing, formulas, and IOL selection.

Comments Off on Cataract surgery in patients with keratoconus

EyeWorld Journal Club review: “Prediction of the small aperture intraocular lens on visual acuity in patients with keratoconus”

The Cullen Eye Institute residents reviewed “Prediction of the small aperture intraocular lens on visual acuity in patients with keratoconus” from the Journal of Cataract & Refractive Surgery.

Comments Off on EyeWorld Journal Club review: “Prediction of the small aperture intraocular lens on visual acuity in patients with keratoconus”

EyeWorld Weekly, December 15, 2023

➤ Positive topline results in Phase 2a trial for treatment of MGD in patients with Demodex ➤ First patient visit in Phase 2b trial evaluating anti-TNFα for dry eye disease ➤ Smart contact lens makes progress ➤ Asset transition ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, December 15, 2023

EyeWorld Weekly, December 8, 2023

➤ Primary, secondary endpoints met in Phase 2 wet AMD trial ➤ Modifications made to investigational glaucoma treatment device ➤ Positive Phase 1/2 data from clinical trial for treatment of Leber congenital amaurosis ➤ Results from first-in-human study of siRNA treatment for AMD ➤ Possibility of a minimally invasive approach for treating AMD ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, December 8, 2023

EyeWorld Weekly, November 17, 2023

➤ World’s first whole-eye transplant ➤ Regenerative Medicine Advanced Therapy designation for investigational therapy for Leber congenital amaurosis ➤ 48-month trial data for retinal prosthesis for patients with severe atrophic AMD ➤ First patient dosed in Phase 1/2 trial for Stargardt disease gene therapy ➤ Partnership to develop molecule targeting DME ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, November 17, 2023

EyeWorld Weekly, November 3, 2023

➤ FDA expands eye drop warning list ➤ Positive results in Phase 2a trial for new biodegradable sustained drug delivery implant ➤ Phase 2b study begins for investigational therapy for acute infectious conjunctivitis ➤ FDA approves additional treatment indication for bispecific antibody ➤ Enrollment complete for study evaluating femtosecond laser-created trabeculotomy ➤ Company to study personalized medicine for patients with wet AMD ➤ Enrollment complete for Phase 2b trial evaluating wet AMD therapy ➤ Pivotal trial for wet AMD therapy begins ➤ Survey evaluates female ophthalmologist experiences ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, November 3, 2023

An update on intracorneal ring segments

In the 20+ years since intracorneal ring segments were first introduced, there have been several advances, both in terms of techniques and materials. EyeWorld spoke with three physicians for the latest in the world of intracorneal ring segments.

Comments Off on An update on intracorneal ring segments

EyeWorld Weekly, July 21, 2023

➤ Study: low-dose atropine doesn’t slow myopia progression ➤ Adverse events reported after use of FDA-approved geographic atrophy drug ➤ Phase 1 data for synthetic cannabinoid being investigated for glaucoma ➤ Enrollment complete in study evaluating topical diabetic retinopathy therapy ➤ Enrollment update for Phase 2b trial that could reduce AMD treatment burden ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, July 21, 2023